Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 32 days ago
Share
A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee
120 patients around the world
Available in
Brazil
Phase II, dose-finding, interventional, three-arm, randomized (1:1:1), double-blind, parallel, active-comparator-controlled clinical trial.
Aptissen SA
1
Research sites
120
Patients around the world
This study is for people with
Osteoarthritis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
ORTOCITY | Lapa - Clínica Ortopédica e de Reabilitação
Recruiting
View site
R. Brg. Gavião Peixoto, 526 - Lapa, São Paulo - SP, 05078-000, Brazil
See details
Contact us
Contact us
Sponsor
Aptissen SA
Conditions
Osteoarthritis
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05337540
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent